Valuation: Clover Corporation Limited

Market Cap 15Cr 11Cr 9.31Cr 8.76Cr 7.96Cr 15Cr 1.03TCr 102.77Cr 40Cr 516.63Cr 40Cr 40Cr 1.72TCr P/E 2026 *
15.6x
P/E 2027 * 11.4x
Enterprise Value 15Cr 11Cr 9.17Cr 8.63Cr 7.84Cr 15Cr 1.02TCr 101.21Cr 40Cr 508.81Cr 40Cr 39Cr 1.69TCr EV / Sales 2026 *
1.59x
EV / Sales 2027 * 1.25x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.14%
1 week-7.58%
Current month-4.69%
1 month+7.02%
3 months-2.66%
6 months+18.83%
Current year+15.82%
1 week 0.92
Extreme 0.915
1
1 month 0.83
Extreme 0.83
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

2,55,199 0.1528%
18/11/25 Buy

Chief Executive Officer

5,29,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-7.58%+67.89%-10.29% 11Cr
+1.26%-6.66%+27.03%+79.23% 1.3TCr
-0.09%+8.88%-16.23%+319.20% 918.05Cr
-1.10%-2.18%-19.98%-49.92% 248.5Cr
+5.09%+0.43%-13.05%-9.97% 142.33Cr
+0.01%-0.32%+26.72%+78.07% 136.4Cr
+2.71%+5.20%+34.68%-19.96% 125.66Cr
+4.27%-8.01%-72.40%-72.11% 118.37Cr
+0.37%-4.53%-38.16% - 110.85Cr
+0.97%+0.69%-61.37%-68.78% 96Cr
Average +1.13%-1.84%-6.49%+27.27% 321.15Cr
Weighted average by Cap. +0.92%-1.61%+1.12%+121.09%

Financials

2026 *2027 *
Net sales 9.4Cr 6.67Cr 5.76Cr 5.42Cr 4.93Cr 9.26Cr 638.99Cr 64Cr 25Cr 319.58Cr 25Cr 24Cr 1.06TCr 12Cr 8.24Cr 7.11Cr 6.69Cr 6.08Cr 11Cr 789.21Cr 79Cr 31Cr 394.72Cr 31Cr 30Cr 1.31TCr
Net income 98L 69.53L 60.05L 56.5L 51.35L 96.58L 67Cr 6.63Cr 2.6Cr 33Cr 2.61Cr 2.55Cr 110.98Cr 1.35Cr 95.78L 82.72L 77.83L 70.74L 1.33Cr 92Cr 9.13Cr 3.58Cr 46Cr 3.6Cr 3.52Cr 152.88Cr
Net Debt -23L -16.32L -14.09L -13.26L -12.05L -22.67L -16Cr -1.56Cr -60.96L -7.82Cr -61.27L -59.94L -26Cr -72L -51.08L -44.12L -41.51L -37.73L -70.96L -49Cr -4.87Cr -1.91Cr -24Cr -1.92Cr -1.88Cr -82Cr
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
18/26/18 A$0.9150 -2.14% 741
17/26/17 A$0.9350 -1.58% 51,022
14/26/14 A$0.9500 +0.53% 89,236
13/26/13 A$0.9450 -4.06% 94,981
12/26/12 A$0.9850 -1.50% 71,539
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9150AUD
Average target price
1.280AUD
Spread / Average Target
+39.89%

Annual profits - Rate of surprise